{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T06:00:16Z","timestamp":1785218416556,"version":"3.55.0"},"reference-count":47,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T00:00:00Z","timestamp":1785196800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Microbiol."],"abstract":"<jats:p>Antibiotics are widely used to prevent and treat early life gut infections, but their aberrant use has raised global concerns about antibiotic resistance. As breastfed infants have fewer intestinal infections than formula-fed infants, this stimulated scientific interest in the anti-pathogenic properties of breastmilk, specifically human milk oligosaccharides (HMOs). HMOs are non-digestible sugars that support infant gut microbiome development, immune maturation, and protection against pathogens. However, to determine how specific HMO structures differentially affect microbial growth and pathogen susceptibility investigating individual HMOs is essential.<\/jats:p>\n                  <jats:p>\n                    This study therefore evaluates the effects of single-structure HMOs and galacto-oligosaccharides (GOS) on the growth of key early-life gut pathogens,\n                    <jats:italic>Escherichia coli, Salmonella enterica, Yersinia enterocolitica<\/jats:italic>\n                    , and\n                    <jats:italic>Clostridium perfringens<\/jats:italic>\n                    . The strongest pathogen inhibitory effects of HMOs were further assessed by colony forming unit enumeration and tested across variable media to confirm oligosaccharide-specific efficacy.\n                  <\/jats:p>\n                  <jats:p>\n                    Oligosaccharide screening revealed clear differences in bacterial growth, with\n                    <jats:italic>S. enterica<\/jats:italic>\n                    most strongly inhibited and\n                    <jats:italic>C. perfringens<\/jats:italic>\n                    exhibiting growth stimulation. Among the tested oligosaccharides, 3\u2032-galactosyllactose and GOS showed the most pronounced growth-inhibitory effects against\n                    <jats:italic>Escherichia coli, Salmonella enterica, Yersinia enterocolitica<\/jats:italic>\n                    . Salt concentration and nutrient richness further modulated oligosaccharide activity, highlighting the multifactorial nature of their antibacterial potential.\n                  <\/jats:p>\n                  <jats:p>Overall, our findings show that oligosaccharides display structure-specific and environment-dependent effects on bacterial growth, indicating that their antimicrobial activity is shaped by oligosaccharide structure, bacterial species, and growth environment.<\/jats:p>","DOI":"10.3389\/fmicb.2026.1854651","type":"journal-article","created":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T05:37:10Z","timestamp":1785217030000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["The impact of human milk oligosaccharides and galacto-oligosaccharides on the growth of early life pathogenic gut bacteria"],"prefix":"10.3389","volume":"17","author":[{"given":"Job T. S.","family":"Schl\u00f6sser","sequence":"first","affiliation":[{"name":"Division of Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Faculty of Science, Utrecht University","place":["Utrecht, Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wendy W. J.","family":"Unger","sequence":"additional","affiliation":[{"name":"Laboratory of Pediatrics, Division of Pediatric Infectious Diseases and Immunology, Erasmus MC University Medical Center Rotterdam \u2013 Sophia Children's Hospital","place":["Rotterdam, Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ad C. J. M.","family":"de Bruijn","sequence":"additional","affiliation":[{"name":"Laboratory of Pediatrics, Division of Pediatric Infectious Diseases and Immunology, Erasmus MC University Medical Center Rotterdam \u2013 Sophia Children's Hospital","place":["Rotterdam, Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dianne J.","family":"Delsing","sequence":"additional","affiliation":[{"name":"Friesland Campina","place":["Amersfoort, Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andre","family":"Groeneveld","sequence":"additional","affiliation":[{"name":"Friesland Campina","place":["Amersfoort, Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arjen","family":"Nauta","sequence":"additional","affiliation":[{"name":"Friesland Campina","place":["Amersfoort, Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gert","family":"Folkerts","sequence":"additional","affiliation":[{"name":"Division of Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Faculty of Science, Utrecht University","place":["Utrecht, Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc M. S. M.","family":"W\u00f6sten","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases and Immunology, Department of Biomolecular Health Sciences, Faculty of Veterinary Medicine, Utrecht University","place":["Utrecht, Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saskia","family":"Braber","sequence":"additional","affiliation":[{"name":"Division of Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Faculty of Science, Utrecht University","place":["Utrecht, Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,7,28]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1021\/acsinfecdis.7b00183","article-title":"Antimicrobial and antibiofilm activity of human milk oligosaccharides against Streptococcus agalactiae, Staphylococcus aureus, and Acinetobacter baumannii","volume":"4","author":"Ackerman","year":"2017","journal-title":"ACS Infect. Dis"},{"key":"B2","doi-asserted-by":"publisher","first-page":"1789","DOI":"10.3390\/nu12061789","article-title":"Anti-pathogenic functions of non-digestible oligosaccharides in vitro","volume":"12","author":"Asadpoor","year":"2020","journal-title":"Nutrients"},{"key":"B3","doi-asserted-by":"publisher","first-page":"2164152","DOI":"10.1080\/19490976.2022.2164152","article-title":"Human milk oligosaccharides, antimicrobial drugs, and the gut microbiota of term neonates: observations from the KOALA birth cohort study","volume":"15","author":"Barnett","year":"2023","journal-title":"Gut microbes"},{"key":"B4","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/j.clnu.2010.08.003","article-title":"Longitudinal analysis of macronutrients and minerals in human milk produced by mothers of preterm infants","volume":"30","author":"Bauer","year":"2011","journal-title":"Clin. Nutr."},{"key":"B5","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1111\/j.1348-0421.1984.tb00754.x","article-title":"The intestinal microflora of infants: composition of fecal flora in breast-fed and bottle-fed infants","volume":"28","author":"Benno","year":"1984","journal-title":"Microbiol. Immunol."},{"key":"B6","doi-asserted-by":"publisher","first-page":"5112","DOI":"10.3390\/nu14235112","article-title":"Human milk oligosaccharides as potential antibiofilm agents: a review","volume":"14","author":"Bhowmik","year":"2022","journal-title":"Nutrients"},{"key":"B7","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1159\/000505339","article-title":"Human milk oligosaccharides: structure and functions","volume":"94","author":"Bode","year":"2020","journal-title":"Nestle Nutr. Inst. Workshop Ser."},{"key":"B8","doi-asserted-by":"publisher","first-page":"4270","DOI":"10.1038\/s41598-020-61024-z","article-title":"The association between breastmilk oligosaccharides and faecal microbiota in healthy breastfed infants at two, six, and 12 weeks of age","volume":"10","author":"Borewicz","year":"2020","journal-title":"Sci. Rep."},{"key":"B9","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1186\/1752-0509-7-27","article-title":"The last generation of bacterial growth in limiting nutrient","volume":"7","author":"Bren","year":"2013","journal-title":"BMC Syst. Biol."},{"key":"B10","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1186\/s40348-022-00146-y","article-title":"Infant formulas with synthetic oligosaccharides and respective marketing practices: position statement of the German society for child and adolescent medicine eV (DGKJ), commission for nutrition","volume":"9","author":"B\u00fchrer","year":"2022","journal-title":"Mol. Cell. Pediatr."},{"key":"B11","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/j.chom.2023.12.014","article-title":"A bacterial sialidase mediates early-life colonization by a pioneering gut commensal","volume":"32","author":"Buzun","year":"2024","journal-title":"Cell Host Microbe"},{"key":"B12","doi-asserted-by":"publisher","first-page":"5033","DOI":"10.3390\/nu14235033","article-title":"Non-digestible oligosaccharides: a novel treatment for respiratory infections?","volume":"14","author":"Cai","year":"2022","journal-title":"Nutrients"},{"key":"B13","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/bs.accb.2015.08.002","article-title":"Human milk oligosaccharides (HMOS): structure, function, and enzyme-catalyzed synthesis","volume":"72","author":"Chen","year":"2015","journal-title":"Adv. Carbohydr. Chem. Biochem."},{"key":"B14","doi-asserted-by":"publisher","first-page":"1755","DOI":"10.1021\/acsinfecdis.8b00234","article-title":"Interrogation of human milk oligosaccharide fucosylation patterns for antimicrobial and antibiofilm trends in group B Streptococcus","volume":"4","author":"Craft","year":"2018","journal-title":"ACS Infect. Dis."},{"key":"B15","doi-asserted-by":"publisher","first-page":"1893","DOI":"10.1039\/C8OB02080A","article-title":"Sialylated variants of lacto-N-tetraose exhibit antimicrobial activity against Group B Streptococcus","volume":"17","author":"Craft","year":"2019","journal-title":"Org. Biomol. Chem."},{"key":"B16","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1038\/s41579-022-00820-y","article-title":"Molecular mechanisms of antibiotic resistance revisited","volume":"21","author":"Darby","year":"2023","journal-title":"Nat. Rev. Microbiol."},{"key":"B17","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1186\/1471-2164-12-168","article-title":"Shotgun sequencing of Yersinia enterocolitica strain W22703 (biotype 2, serotype O: 9): genomic evidence for oscillation between invertebrates and mammals","volume":"12","author":"Fuchs","year":"2011","journal-title":"BMC genomics"},{"key":"B18","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1038\/s42003-022-03336-6","article-title":"Nutrient and salt depletion synergistically boosts glucose metabolism in individual Escherichia coli cells","volume":"5","author":"Glover","year":"2022","journal-title":"Commun. Biol."},{"key":"B19","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1038\/s41575-022-00594-x","article-title":"Bench to bedside\u2014new insights into the pathogenesis of necrotizing enterocolitis","volume":"19","author":"Hackam","year":"2022","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"B20","doi-asserted-by":"publisher","first-page":"1326","DOI":"10.1038\/mi.2014.20","article-title":"Human colostrum oligosaccharides modulate major immunologic pathways of immature human intestine","volume":"7","author":"He","year":"2014","journal-title":"Mucosal Immunol."},{"key":"B21","doi-asserted-by":"publisher","first-page":"533","DOI":"10.3390\/pathogens13070533","article-title":"Difference in the intestinal microbiota between breastfeed infants and infants fed with artificial milk: a systematic review","volume":"13","author":"Inchingolo","year":"2024","journal-title":"Pathogens"},{"key":"B22","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1186\/s13073-016-0294-z","article-title":"The effects of antibiotics on the microbiome throughout development and alternative approaches for therapeutic modulation","volume":"8","author":"Langdon","year":"2016","journal-title":"Genome Med."},{"key":"B23","doi-asserted-by":"publisher","first-page":"11243","DOI":"10.1074\/jbc.M117.789974","article-title":"Human milk oligosaccharides inhibit growth of group B Streptococcus","volume":"292","author":"Lin","year":"2017","journal-title":"J. Biol. Chem."},{"key":"B24","doi-asserted-by":"publisher","first-page":"7800","DOI":"10.1021\/acs.jafc.0c02684","article-title":"Touching the high complexity of prebiotic vivinal galacto-oligosaccharides using porous graphitic carbon ultra-high-performance liquid chromatography coupled to mass spectrometry","volume":"68","author":"Logtenberg","year":"2020","journal-title":"J. Agric. Food Chem."},{"key":"B25","doi-asserted-by":"publisher","first-page":"576","DOI":"10.7167\/2013\/219095","article-title":"Viability of Escherichia coli ATCC 8739 in nutrient broth, luria-bertani broth and brain heart infusion over 11 weeks","volume":"5","author":"Low","year":"2013","journal-title":"Electron. Physician"},{"key":"B26","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1038\/s41579-022-00768-z","article-title":"Microbiota succession throughout life from the cradle to the grave","volume":"20","author":"Martino","year":"2022","journal-title":"Nat. Rev. Microbiol."},{"key":"B27","doi-asserted-by":"publisher","first-page":"586","DOI":"10.3390\/toxins15100586","article-title":"Protective effects of alginate and Chitosan oligosaccharides against clostridioides difficile bacteria and toxin","volume":"15","author":"Mavrogeni","year":"2023","journal-title":"Toxins"},{"key":"B28","doi-asserted-by":"publisher","first-page":"10846","DOI":"10.1038\/s41598-022-14260-4","article-title":"In silico analysis of the human milk oligosaccharide glycome reveals key enzymes of their biosynthesis","volume":"12","author":"McDonald","year":"2022","journal-title":"Sci. Rep."},{"key":"B29","doi-asserted-by":"publisher","first-page":"2091","DOI":"10.1039\/D3OB02069J","article-title":"Gram-scale chemical synthesis of galactosyllactoses and their impact on infant gut microbiota in vitro","volume":"22","author":"Meeusen","year":"2024","journal-title":"Org. Biomol. Chem."},{"key":"B30","doi-asserted-by":"publisher","first-page":"111601","DOI":"10.1016\/j.nut.2022.111601","article-title":"Galactooligosaccharides and 2\u2032-fucosyllactose can directly suppress growth of specific pathogenic microbes and affect phagocytosis of neutrophils","volume":"96","author":"Mortaz","year":"2022","journal-title":"Nutrition"},{"key":"B31","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1016\/S0140-6736(21)02724-0","article-title":"Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis","volume":"399","author":"Murray","year":"2022","journal-title":"Lancet"},{"key":"B32","doi-asserted-by":"publisher","first-page":"2478306","DOI":"10.1080\/19490976.2025.2478306","article-title":"In vitro competition with Bifidobacterium strains impairs potentially pathogenic growth of Clostridium perfringens on 2\u2032-fucosyllactose","volume":"17","author":"Nakajima","year":"2025","journal-title":"Gut Microbes"},{"key":"B33","doi-asserted-by":"publisher","first-page":"e01849","DOI":"10.1128\/aem.01849-21","article-title":"Decomposition of growth curves into growth rate and acceleration: a novel procedure to monitor bacterial growth and the time-dependent effect of antimicrobials","volume":"88","author":"Navarro-P\u00e9rez","year":"2022","journal-title":"Appl. Environ. Microbiol."},{"key":"B34","doi-asserted-by":"publisher","first-page":"358","DOI":"10.3945\/jn.115.220749","article-title":"Human milk oligosaccharides and synthetic galactosyloligosaccharides contain 3\u2032-, 4-, and 6\u2032-galactosyllactose and attenuate inflammation in human T84, NCM-460, and H4 cells and intestinal tissue ex vivo","volume":"146","author":"Newburg","year":"2016","journal-title":"J. Nutr."},{"key":"B35","doi-asserted-by":"publisher","first-page":"1793871","DOI":"10.3389\/fmicb.2026.1793871","article-title":"Despite inducing antioxidant regulation, superoxide dismutase deficiency makes Escherichia coli more sensitive to hydrogen peroxide","volume":"17","author":"Nong","year":"2026","journal-title":"Front. Microbiol."},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1136\/ebnurs-2022-103540","article-title":"Antimicrobial resistance collaborators (2022). global burden of bacterial antimicrobial resistance in 2019: a systematic analysis","author":"Ranjbar","year":"2023","journal-title":"Evid.-Based Nurs."},{"key":"B37","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1186\/s40168-025-02034-9","article-title":"Modulating the developing gut microbiota with 2\u2032-fucosyllactose and pooled human milk oligosaccharides","volume":"13","author":"Renwick","year":"2025","journal-title":"Microbiome"},{"key":"B38","unstructured":"Microbial growth protocols\n          \n          2022"},{"key":"B39","doi-asserted-by":"publisher","first-page":"110884","DOI":"10.1016\/j.foodres.2021.110884","article-title":"Recent understanding of human milk oligosaccharides in establishing infant gut microbiome and roles in immune system","volume":"151","author":"Singh","year":"2022","journal-title":"Food Res. Int."},{"key":"B40","doi-asserted-by":"publisher","first-page":"2737","DOI":"10.3390\/nu13082737","article-title":"The mean of milk: a review of human milk oligosaccharide concentrations throughout lactation","volume":"13","author":"Soyyilmaz","year":"2021","journal-title":"Nutrients"},{"key":"B41","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1016\/j.chom.2022.03.013","article-title":"The resistance within: antibiotic disruption of the gut microbiome and resistome dynamics in infancy","volume":"30","author":"Th\u00e4nert","year":"2022","journal-title":"Cell Host Microbe"},{"key":"B42","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.carres.2016.03.006","article-title":"Comparative structural characterization of 7 commercial galacto-oligosaccharide (GOS) products","volume":"425","author":"Van Leeuwen","year":"2016","journal-title":"Carbohydr. Res."},{"key":"B43","doi-asserted-by":"publisher","first-page":"104074","DOI":"10.1016\/j.jff.2020.104074","article-title":"Human milk oligosaccharides: shaping the infant gut microbiota and supporting health","volume":"72","author":"Walsh","year":"2020","journal-title":"J. Funct. Foods"},{"key":"B44","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1159\/000494757","article-title":"Influence of laboratory culture media on in vitro growth, adhesion, and biofilm formation of Pseudomonas aeruginosa and Staphylococcus aureus","volume":"28","author":"Wijesinghe","year":"2019","journal-title":"Medical Principles and Practice"},{"key":"B45","unstructured":"Preparing spread plates protocols\n          \n          \n            \n              Wise\n              K.\n            \n          \n          Am. Soc. Microbiol. Microbe Libr.\n          \n          2006"},{"key":"B46","year":"2019"},{"key":"B47","doi-asserted-by":"publisher","first-page":"2430418","DOI":"10.1080\/19490976.2024.2430418","article-title":"Human milk oligosaccharides combine with Bifidobacterium longum to form the \u201cgolden shield\u201d of the infant intestine: metabolic strategies, health effects, and mechanisms of action","volume":"16","author":"Yang","year":"2024","journal-title":"Gut Microbes"}],"container-title":["Frontiers in Microbiology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmicb.2026.1854651\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T05:37:11Z","timestamp":1785217031000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmicb.2026.1854651\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,28]]},"references-count":47,"alternative-id":["10.3389\/fmicb.2026.1854651"],"URL":"https:\/\/doi.org\/10.3389\/fmicb.2026.1854651","relation":{},"ISSN":["1664-302X"],"issn-type":[{"value":"1664-302X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,28]]},"article-number":"1854651"}}